Cancer patient self-reporting reliable and feasible, studies show August 14, 2017 Men with newly diagnosed prostate cancer (PCa) can reliably report their comorbidities, and participants in cancer clinical trials “are willing and able” to report symptomatic adverse events (AEs), according to the findings of separate studies published in JAMA Oncology.Read more. Source: Renal and Urology News About Prostate Cancer Prostate Cancer News Research More for you
Men with newly diagnosed prostate cancer (PCa) can reliably report their comorbidities, and participants in cancer clinical trials “are willing and able” to report symptomatic adverse events (AEs), according to the findings of separate studies published in JAMA Oncology.Read more. Source: Renal and Urology News
Donate Now
